Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.52 USD
+0.24 (7.32%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.51 -0.01 (-0.28%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $-0.09 | -25.92% |
Earnings Summary
For their last quarter, Aquestive Therapeutics (AQST) reported earnings of -$0.12 per share, missing the Zacks Consensus Estimate of -$0.08 per share. This reflects a negative earnings surprise of 50.00%. Look out for AQST's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 181.82%.
Earnings History
Price & Consensus
Zacks News for AQST
Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services